Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Sci Rep ; 7: 41151, 2017 01 24.
Article in English | MEDLINE | ID: mdl-28117344

ABSTRACT

While evidence for lung cancer screening implementation in Europe is awaited, Rapid Diagnostic Units have been established in many hospitals to accelerate the early diagnosis of lung cancer. We seek to develop an algorithm to detect lung cancer in a symptomatic population attending such unit, based on a sensitive serum marker panel. Serum concentrations of Epidermal Growth Factor, sCD26, Calprotectin, Matrix Metalloproteinases -1, -7, -9, CEA and CYFRA 21.1 were determined in 140 patients with respiratory symptoms (lung cancer and controls with/without benign pathology). Logistic Lasso regression was performed to derive a lung cancer prediction model, and the resulting algorithm was tested in a validation set. A classification rule based on EGF, sCD26, Calprotectin and CEA was established, able to reasonably discriminate lung cancer with 97% sensitivity and 43% specificity in the training set, and 91.7% sensitivity and 45.4% specificity in the validation set. Overall, the panel identified with high sensitivity stage I non-small cell lung cancer (94.7%) and 100% small-cell lung cancers. Our study provides a sensitive 4-marker classification algorithm for lung cancer detection to aid in the management of suspicious lung cancer patients in the context of Rapid Diagnostic Units.


Subject(s)
Biomarkers, Tumor/blood , Lung Neoplasms/diagnosis , Aged , Algorithms , Female , Humans , Lung Neoplasms/blood , Male , Neoplasm Staging , Sensitivity and Specificity
2.
PLoS One ; 10(5): e0127318, 2015.
Article in English | MEDLINE | ID: mdl-25992884

ABSTRACT

Lung cancer is the most lethal neoplasia, and an early diagnosis is the best way for improving survival. Symptomatic patients attending Pulmonary Services could be diagnosed with lung cancer earlier if high-risk individuals are promptly separated from healthy individuals and patients with benign respiratory pathologies. We searched for a convenient non-invasive serum test to define which patients should have more immediate clinical tests. Six cancer-associated molecules (HB-EGF, EGF, EGFR, sCD26, VEGF, and Calprotectin) were investigated in this study. Markers were measured in serum by specific ELISAs, in an unselected population that included 72 lung cancer patients of different histological types and 56 control subjects (healthy individuals and patients with benign pulmonary pathologies). Boosted regression and random forests analysis were conducted for the selection of the best candidate biomarkers. A remarkable discriminatory capacity was observed for EGF, sCD26, and especially for Calprotectin, these three molecules constituting a marker panel boasting a sensitivity of 83% and specificity of 87%, resulting in an associated misclassification rate of 15%. Finally, an algorithm derived by logistic regression and a nomogram allowed generating classification scores in terms of the risk of a patient of suffering lung cancer. In conclusion, we propose a non-invasive test to identify patients at high-risk for lung cancer from a non-selected population attending a Pulmonary Service. The efficacy of this three-marker panel must be tested in a larger population for lung cancer.


Subject(s)
Biomarkers, Tumor/blood , Carcinoma, Non-Small-Cell Lung/diagnosis , Early Detection of Cancer/methods , Lung Neoplasms/diagnosis , Aged , Aged, 80 and over , Algorithms , Carcinoma, Non-Small-Cell Lung/blood , Dipeptidyl Peptidase 4/blood , Epidermal Growth Factor/blood , Female , Humans , Leukocyte L1 Antigen Complex/blood , Logistic Models , Lung Neoplasms/blood , Male , Middle Aged , Prospective Studies , Sensitivity and Specificity
3.
PLoS One ; 9(9): e107470, 2014.
Article in English | MEDLINE | ID: mdl-25210927

ABSTRACT

One of the main aims of the follow-up after curative resection of colorectal cancer is the early detection and treatment of tumor recurrence. We previously demonstrated decreased preoperative soluble CD26 (sCD26) levels in serum from colorectal cancer patients. We extended now the study to investigate if sCD26 levels in postoperative serum serve as marker of recurrence of the disease during surveillance. Soluble sCD26 was measured in pre- and postoperative serum samples of 43 patients with primary colorectal cancer. Carcinoembryonic antigen, carbohydrate antigen 19.9 and 72.4 levels were also measured during surveillance. The average follow-up period was 41.8 ± 20.8 months. sCD26 levels during follow-up showed well-defined patterns in patients without disease (n = 28), and in patients with tumor persistence (n = 2), local recurrence (n = 3) or distant metastasis (n = 10). Disease-free patients showed stable levels between 460-850 ng/mL during follow-up, while high (over 850 ng/mL) and unstable sCD26 levels were found before recurrence was diagnosed. The mean maximum/minimum sCD26 ratios during surveillance were 1.52, 2.12 and 2.63 for patients with no recurrence, local recurrence and metastasis, respectively (p = 0.005). From the cut-off obtained from a receiver operator characteristics (ROC) curve built with the maximum/minimum sCD26 ratios and the upper and lower cut-offs of sCD26, we were able to discriminate patients with and without recurrent disease. We propose that the measurement of serum sCD26 during the follow-up of patients diagnosed of colorectal cancer could be valuable for the early detection of local and distant recurrence. A large, randomized, prospective trial should be performed to confirm our findings.


Subject(s)
Biomarkers, Tumor/blood , Colorectal Neoplasms/blood , Dipeptidyl Peptidase 4/blood , Liver Neoplasms/blood , Neoplasm Recurrence, Local/blood , Aged , Colorectal Neoplasms/pathology , Colorectal Neoplasms/surgery , Female , Humans , Liver Neoplasms/secondary , Liver Neoplasms/surgery , Male , Middle Aged , Neoplasm Recurrence, Local/prevention & control , ROC Curve
4.
Sci Rep ; 4: 3999, 2014 Feb 06.
Article in English | MEDLINE | ID: mdl-24499783

ABSTRACT

In this study, we measured ADA and DPP-IV enzymatic activity and sCD26 concentration in 150 pleural effusion (PE) samples and tested for correlations between these and other cellular and biochemical measures. We found that DPP-IV in particular might improve the specificity (but not the sensitivity) of the ADA test for diagnosis of pulmonary tuberculosis, since half of the false ADA positive results in non-tuberculous PE were also DPP-IV positive. A percentage of patients with malignant PE were sCD26 or DPP-IV positive; however, some patients with benign PE also tested positive. As a pattern associated with DPP-IV (but not the CD26 protein) was observed in PE, we searched for a finding that might increase the value of these biomarkers for diagnosis of malignancy. The observed pattern was related to the presence of leukocytes, as indicated by correlations with the cell count, and to a band of 180 kDa, detected by immunoblotting.


Subject(s)
Adenosine Deaminase/biosynthesis , Dipeptidyl Peptidase 4/biosynthesis , Pleural Effusion/metabolism , Tuberculosis, Pleural/diagnosis , Adult , Aged , Aged, 80 and over , Biomarkers , Exudates and Transudates , Female , Humans , Interferon-gamma/analysis , Leukocyte Count , Male , Middle Aged , Th1 Cells/immunology , Tuberculosis, Pleural/immunology , Young Adult
5.
World J Clin Oncol ; 2(6): 245-61, 2011 Jun 10.
Article in English | MEDLINE | ID: mdl-21773075

ABSTRACT

Colorectal cancer is characterized by a low survival rate even though the basis for colon cancer development, which involves the evolution of adenomas to carcinoma, is known. Moreover, the mortality rates continue to rise in economically transitioning countries although there is the opportunity to intervene in the natural history of the adenoma-cancer sequence through risk factors, screening, and treatment. Screening in particular accounted for most of the decline in colorectal cancer mortality achieved in the USA during the period 1975-2000. Patients show a better prognosis when the neoplasm is diagnosed early. Among the variety of screening strategies, the methods range from invasive and costly procedures such as colonoscopy to more low-cost and non-invasive tests such as the fecal occult blood test (guaiac and immunochemical). As a non-invasive biological serum marker would be of great benefit because of the performance of the test, several biomarkers, including cytologic assays, DNA and mRNA, and soluble proteins, have been studied. We found that the soluble CD26 (sCD26) concentration is diminished in serum of colorectal cancer patients compared to healthy donors, suggesting the potential utility of a sCD26 immunochemical detection test for early diagnosis. sCD26 originates from plasma membrane CD26 lacking its transmembrane and cytoplasmic domains. Some 90%-95% of sCD26 has been associated with serum dipeptidyl peptidase IV (DPP-IV) activity. DPP-IV, assigned to the CD26 cluster, is a pleiotropic enzyme expressed mainly on epithelial cells and lymphocytes. Our studies intended to validate this test for population screening to detect colorectal cancer and advanced adenomas are reviewed here.

6.
BMC Evol Biol ; 10: 65, 2010 Mar 08.
Article in English | MEDLINE | ID: mdl-20210986

ABSTRACT

BACKGROUND: The role of phenotypic plasticity is increasingly being recognized in the field of evolutionary studies. In this paper we look at the role of genetic determination versus plastic response by comparing the protein expression profiles between two sympatric ecotypes adapted to different shore levels and habitats using two-dimensional protein maps. RESULTS: We compared qualitative and quantitative differences in protein expression between pools of both ecotypes from different environments (field and laboratory conditions). The results suggested that ecotype differences may affect about 7% of the proteome in agreement with previous studies, and moreover these differences are basically insensitive to environmental changes. Thus, observed differences between wild ecotypes can be mainly attributed to genetic factors rather than phenotypic plasticity. CONCLUSIONS: These results confirm the mechanism of adaptation already proposed in this species and a minor role of phenotypic plasticity in this ecological speciation process. In addition, this study provides a number of interesting protein spots potentially involved in adaptation, and therefore candidates for a future identification.


Subject(s)
Proteome/analysis , Snails/chemistry , Snails/genetics , Animals , Cluster Analysis , Ecosystem , Electrophoresis, Gel, Two-Dimensional , Phenotype
7.
Dis Markers ; 27(6): 311-6, 2009.
Article in English | MEDLINE | ID: mdl-20075514

ABSTRACT

INTRODUCTION: Previous studies have suggested the use of soluble CD26 (sCD26) as a tumour marker for the detection of colorectal cancer (CRC) and advanced adenomas. The aim of this study was to assess the sCD26 concentration in a large cohort to evaluate its association to epidemiologic parameters and CRC-related symptoms/pathologies. SUBJECTS AND METHODS: Serum samples were collected from 2,754 putatively healthy individuals with ages ranging from 30-65 years, and with personal or familial history of polyps, CRC and/or CR symptoms. sCD26 levels were measured by ELISA. RESULTS: No association was found between the sCD26 concentration and age (< 50 and 50), the personal or familial history of polyps or CRC, rectal bleeding, haemorrhoids or diverticula. However, sCD26 was related to non-inflammatory benign pathologies (excluding rectal bleeding, changes in bowel habits, haemorrhoids, diverticula) and to inflammatory benign pathologies. DISCUSSION: Our results confirm that the sCD26 can be easily offered and evaluated in a large cohort. Additionally, the validation of sCD26 as a tumour marker for screening and case-finding purposes requires a further comparison with an established non-invasive test like the faecal occult blood.


Subject(s)
Dipeptidyl Peptidase 4/blood , Gastrointestinal Diseases/blood , Gastrointestinal Diseases/epidemiology , Adult , Age Factors , Aged , Biomarkers/blood , Cohort Studies , Colorectal Neoplasms/blood , Colorectal Neoplasms/epidemiology , Diverticulum/blood , Diverticulum/epidemiology , Female , Fissure in Ano/blood , Fissure in Ano/epidemiology , Gastrointestinal Diseases/pathology , Gastrointestinal Hemorrhage/blood , Gastrointestinal Hemorrhage/epidemiology , Gastrointestinal Tract/pathology , Gastrointestinal Tract/physiopathology , Hemorrhoids/blood , Hemorrhoids/epidemiology , Humans , Inflammation/blood , Inflammation/epidemiology , Intestinal Polyps/blood , Intestinal Polyps/epidemiology , Irritable Bowel Syndrome/blood , Irritable Bowel Syndrome/epidemiology , Male , Middle Aged , Rectum/pathology , Rectum/physiopathology
8.
Biol Chem ; 389(4): 425-32, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18208347

ABSTRACT

Apart from its esterase activity, butyrylcholinesterase (BuChE) displays aryl acylamidase (AAA) activity able to hydrolyze o-nitroacetanilide (ONA) and its trifluoro-derivative (F-ONA). We report here that, despite amidase and esterase sites residing in the same protein, in human samples depleted of acetylcholinesterase the ratio of amidase to esterase activity varied depending on the source of BuChE. The much faster degradation of ONA and F-ONA by BuChE monomers (G1) of colon and kidney than by the tetramers (G4) suggests aggregation-driven differences in the AAA site between single and polymerized subunits. The similar ratio of F-ONAto butyrylthiocholine hydrolysis by serum G1 and G4 forms support structural differences in the amidase site according to the source of BuChE. The changing ratios of amidase to esterase activities in the human sources probably arise from post-translational modifications in BuChE subunits, the specific proportion of monomers and oligomers and the variable capacity of the tetramers for degrading ONA and F-ONA. The elevated amidase activity of BuChE monomers and the scant activity of the tetramers justify the occurrence of single BuChE subunits in cells as a means to sustain the AAA activity of BuChE which otherwise could be lost by tetramerization.


Subject(s)
Amidohydrolases/metabolism , Butyrylcholinesterase/metabolism , Acetanilides/chemistry , Acetanilides/metabolism , Amidohydrolases/blood , Butyrylcholinesterase/blood , Cholinesterases/blood , Cholinesterases/metabolism , Colon/metabolism , Humans , Kidney/metabolism , Molecular Structure , Substrate Specificity
9.
J Hum Genet ; 52(6): 553-556, 2007.
Article in English | MEDLINE | ID: mdl-17427030

ABSTRACT

Fucosidosis is a rare lysosomal storage disease caused by a defect of the alpha-L: -fucosidase (FUCA1) gene. Worldwide 26 mutations underlying the disease have been reported. By direct DNA sequencing of exons and flanking introns, homozygous Y126X mutation and Q281R polymorphism were found in a Taiwanese patient with fucosidosis. Upon expressing in COS-7 cells, 97.4% of alpha-L: -fucosidase activity compared with that of the wild-type construct was observed in the cDNA containing Q281R polymorphism. Western blot analysis revealed a 58-kDa precursor and 56-kDa mature forms for cells transfected with wild-type and Q281R enzymes. Using the fluorogenic substrate, the Michaelis constants and maximal velocities of both enzymes were very similar. While no appreciable enzyme activity (0.0%) was observed with Y126X mutation, no apparent decrease in FUCA1 mRNA level was seen with Y126X mutation. The expressed truncated Y126X protein was unstable and largely degraded. The delineation of the molecular defect could serve to complement future prenatal diagnosis for this family when necessary.


Subject(s)
Fucosidosis/genetics , Mutation , Polymorphism, Genetic , alpha-L-Fucosidase/genetics , Adult , Female , Humans , Taiwan
10.
J Mol Neurosci ; 30(1-2): 51-4, 2006.
Article in English | MEDLINE | ID: mdl-17192624

ABSTRACT

Apart from the hydrolysis of acetylcholine (ACh), acetyl- (AChE) and butyrylcholinesterase (BChE), through noncatalytic mechanisms, intervene in hematopoiesis, morphogenesis, and neurogenesis (Layer and Willbold, 1995; Soreq and Seidman, 2001). Cholinesterase (ChE) molecules occur as globular (G1, G2, and G4) and asymmetric (A4, A8, and A12) forms (Legay, 2000; Massoulié, 2002). The G species might display amphiphilic (GA) or hydrophilic (GH) properties (Perrier et al., 2002). The involvement of ChEs in tumorigenesis is supported by the measurement of ChE activity in tumors (García-Ayllón et al., 2001; Ruiz-Espejo et al., 2003), the amplification of ChE genes in leukemias and ovarian tumors, and the relationship between the expression of AChE and the aggressiveness of astrocytomas(Perry et al., 2002). This research was undertaken to determine whether ChE activity is altered in gut carcinomas.


Subject(s)
Acetylcholinesterase/metabolism , Adenocarcinoma/enzymology , Butyrylcholinesterase/metabolism , Colonic Neoplasms/enzymology , Colon/enzymology , Humans , Kinetics , Rectum/enzymology , Reference Values
11.
Mol Cell Proteomics ; 5(9): 1647-57, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16854844

ABSTRACT

Clusterin is an enigmatic protein altered in tumors of colorectal cancer patients. Because there is no information available about serum clusterin regarding this pathology, we applied proteomic techniques to analyze its isoforms in donors and patients. First we separated serum proteins through concanavalin A, obtaining a fraction with non- and O-glycosylated proteins (FI) and a second fraction enriched in N-glycoproteins (FII) wherein clusterin was supposed to elute on the basis of its glycosylation. Surprisingly analysis of the FI fraction revealed the existence of an unexpected and aberrantly N-glycosylated clusterin that was overexpressed in patients and comprised at least five isoforms with different isoelectric points. On the other hand, two-dimensional electrophoretic analysis of the clusterin eluted in FII detected one isoform that was increased and 15 isoforms that were decreased or absent in serum of patients. Finally immunoquantification by slot blot showed that in total serum and in FI the clusterin levels were significantly increased in patients, whereas in FII there was no significant variation. Therefore, serum clusterin and some of its isoforms could have a potential value as colorectal tumor markers and are interesting subjects for biomarker studies.


Subject(s)
Biomarkers, Tumor/blood , Blood Proteins/analysis , Clusterin/blood , Colorectal Neoplasms/blood , Biomarkers, Tumor/isolation & purification , Blood Proteins/isolation & purification , Chromatography, Affinity , Colorectal Neoplasms/diagnosis , Concanavalin A/metabolism , Electrophoresis, Gel, Two-Dimensional , Female , Glycosylation , Humans , Male , Middle Aged , Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase/metabolism , Protein Isoforms , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
12.
Int J Oncol ; 20(2): 367-72, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11788903

ABSTRACT

A method to improve the reactivity to specific lectins of N-glycoproteins isolated from human colorectal mucosa and from adenocarcinoma biopsies was developed using a combination of techniques. Total protein extracts were subjected to affinity chromatography, using the immobilised lectin Concanavalin A coupled to Sepharose, by fast performance liquid chromatography (FPLC). N-glycoprotein enriched fractions were resolved by SDS-PAGE, transferred to PVDF membranes and incubated with various lectins. Digoxigenin-conjugated SNA I and MAA lectins were used to detect sialic acid residues. Biotin-conjugated UEA I lectin was used to detect L-fucose residues. By this method, lectin-binding N-glycoproteins were found in a broad relative molecular mass (Mr) range (from 47 to 205 kDa). No tissue-specific N-glycoproteins were observed when human colorectal mucosa and adenocarcinoma samples were compared.


Subject(s)
Adenocarcinoma/chemistry , Colorectal Neoplasms/chemistry , Fucose/analysis , Glycoproteins/analysis , Glycoproteins/chemistry , Intestinal Mucosa/chemistry , Lectins/isolation & purification , N-Acetylneuraminic Acid/analysis , Biomarkers, Tumor/analysis , Biomarkers, Tumor/chemistry , Biopsy , Chromatography, Affinity , Chromatography, High Pressure Liquid , Concanavalin A/metabolism , Electrophoresis, Polyacrylamide Gel , Humans , Lectins/metabolism , Membranes, Artificial , Molecular Weight , Organ Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...